Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Lazo-Langner

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
American Journal of Hematology|June 21, 2023
Risk of venous thromboembolism or hemorrhage among individuals with chronic kidney disease on prophylactic anticoagulant after hip or knee arthroplastyTzu-Fei Wang, Nicholas Grubic, Marc Carrier, et al.
Blood Advances|April 12, 2019
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline updateJulia Bohlius, Kari Bohlke, Roberto Castelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2019
Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline UpdateJulia Bohlius, Kari Bohlke, Roberto Castelli, et al.
Circulation|June 9, 2012
Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolismMartha L Louzada, Marc Carrier, Alejandro Lazo-Langner, et al.
CMAJ Open|November 8, 2022
Secondary causes of elevated hemoglobin in patients undergoing molecular testing for suspected polycythemia vera in southwestern Ontario: a chart reviewBenjamin Chin-Yee, Maxim Matyashin, Ian Cheong, et al.
Journal of Thrombosis and Haemostasis : JTH|July 18, 2025
Validation of the ToDay, a simplified diagnostic algorithm for deep vein thrombosisSasha Sharma, Linnea Soon, Kerstin de Wit, et al.
Plos One|November 25, 2011
Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiationInna Y Gong, Ute I Schwarz, Natalie Crown, et al.
Journal of Thrombosis and Haemostasis : JTH|January 29, 2023
The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolismLucia Caiano, Michael J Kovacs, Alejandro Lazo-Langner, et al.
Journal of General Internal Medicine|November 30, 2022
A Rational Approach to JAK2 Mutation Testing in Patients with Elevated Hemoglobin: Results from the JAK2 Prediction Cohort (JAKPOT) StudyBenjamin Chin-Yee, Pratibha Bhai, Ian Cheong, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 22, 2017
Risk of Venous Thromboembolism in Patients by Albuminuria and Estimated GFRDavid Massicotte-Azarniouch, Anan Bader Eddeen, Alejandro Lazo-Langner, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
American Journal of Hematology|June 21, 2023
Risk of venous thromboembolism or hemorrhage among individuals with chronic kidney disease on prophylactic anticoagulant after hip or knee arthroplastyTzu-Fei Wang, Nicholas Grubic, Marc Carrier, et al.
Blood Advances|April 12, 2019
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline updateJulia Bohlius, Kari Bohlke, Roberto Castelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2019
Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline UpdateJulia Bohlius, Kari Bohlke, Roberto Castelli, et al.
Circulation|June 9, 2012
Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolismMartha L Louzada, Marc Carrier, Alejandro Lazo-Langner, et al.
CMAJ Open|November 8, 2022
Secondary causes of elevated hemoglobin in patients undergoing molecular testing for suspected polycythemia vera in southwestern Ontario: a chart reviewBenjamin Chin-Yee, Maxim Matyashin, Ian Cheong, et al.
Journal of Thrombosis and Haemostasis : JTH|July 18, 2025
Validation of the ToDay, a simplified diagnostic algorithm for deep vein thrombosisSasha Sharma, Linnea Soon, Kerstin de Wit, et al.
Plos One|November 25, 2011
Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiationInna Y Gong, Ute I Schwarz, Natalie Crown, et al.
Journal of Thrombosis and Haemostasis : JTH|January 29, 2023
The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolismLucia Caiano, Michael J Kovacs, Alejandro Lazo-Langner, et al.
Journal of General Internal Medicine|November 30, 2022
A Rational Approach to JAK2 Mutation Testing in Patients with Elevated Hemoglobin: Results from the JAK2 Prediction Cohort (JAKPOT) StudyBenjamin Chin-Yee, Pratibha Bhai, Ian Cheong, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 22, 2017
Risk of Venous Thromboembolism in Patients by Albuminuria and Estimated GFRDavid Massicotte-Azarniouch, Anan Bader Eddeen, Alejandro Lazo-Langner, et al.
Pageof 14